Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38
Selected Variant
T9901A-1093-01
Size: 1 mg
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Sodium Channel, Topoisomerase
Related Pathways
Membrane transporter/Ion channel, Antibody-drug Conjugate/ADC Related, DNA Damage/DNA Repair
Bioactivity
Anti-SLC34A2 (Lifastuzumab) -MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human-derived anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the Mc-VC-PAB connector and the topoisomeraseI inhibitor SN38. The ADC's cytotoxic component and linker are Mc-VC-PAB-SN38. This compound is utilized in cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PA1936-Biotin 100 µg/Vial
Anti-mtTFA/TFAM Antibody Picoband® (Biotine Conjugate)
Sign In for Pricing
View Details 
BNC042430-500 1x 500 µL
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker) (YBX1/2430), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB1541-100 1x 100 µL
Calnexin (Endoplasmic Reticulum Marker) (CANX/1541), 0.2mg/mL
Sign In for Pricing
View Details 
BNC682097-100 1x 100 µL
Human IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IgD26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
A01142-PE 100 µg/Vial
Anti-HP1 gamma/CBX3 Antibody Picoband® (PE Conjugate)
Sign In for Pricing
View Details